-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The aggregate expense recognized in the current period that allocates the cost of tangible assets, intangible assets, or depleting assets to periods that benefit from use of the assets.
-
Summary
-
Finch Therapeutics Group, Inc. quarterly/annual Depreciation, Depletion and Amortization history and growth rate from Q1 2020 to Q1 2024.
- Finch Therapeutics Group, Inc. Depreciation, Depletion and Amortization for the quarter ending March 31, 2024 was $43K, a 96.9% decline year-over-year.
- Finch Therapeutics Group, Inc. annual Depreciation, Depletion and Amortization for 2023 was $1.52M, a 72.4% decline from 2022.
- Finch Therapeutics Group, Inc. annual Depreciation, Depletion and Amortization for 2022 was $5.51M, a 139% increase from 2021.
- Finch Therapeutics Group, Inc. annual Depreciation, Depletion and Amortization for 2021 was $2.3M, a 191% increase from 2020.
Depreciation, Depletion and Amortization, Quarterly (USD)
Depreciation, Depletion and Amortization, YoY Quarterly Growth (%)